Idexx Laboratories (IDXX) Accumulated Expenses (2016 - 2025)
Idexx Laboratories has reported Accumulated Expenses over the past 17 years, most recently at $530.1 million for Q4 2025.
- Quarterly results put Accumulated Expenses at $530.1 million for Q4 2025, up 5.58% from a year ago — trailing twelve months through Dec 2025 was $530.1 million (up 5.58% YoY), and the annual figure for FY2025 was $530.1 million, up 5.58%.
- Accumulated Expenses for Q4 2025 was $530.1 million at Idexx Laboratories, up from $488.9 million in the prior quarter.
- Over the last five years, Accumulated Expenses for IDXX hit a ceiling of $541.1 million in Q2 2024 and a floor of $366.9 million in Q1 2021.
- Median Accumulated Expenses over the past 5 years was $432.4 million (2021), compared with a mean of $447.3 million.
- Biggest five-year swings in Accumulated Expenses: skyrocketed 48.43% in 2021 and later dropped 22.94% in 2025.
- Idexx Laboratories' Accumulated Expenses stood at $458.9 million in 2021, then dropped by 5.5% to $433.7 million in 2022, then increased by 10.39% to $478.7 million in 2023, then rose by 4.89% to $502.1 million in 2024, then increased by 5.58% to $530.1 million in 2025.
- The last three reported values for Accumulated Expenses were $530.1 million (Q4 2025), $488.9 million (Q3 2025), and $417.0 million (Q2 2025) per Business Quant data.